Creative Touch Permanent Makeup and Aesthetics

Growth arrest-specific protein 6 (GAS6) is a Vitamin K-dependent protein that serves as the essential “activation key” for the hair follicle. Produced by the Dermal Papilla, it travels to the hair follicle bulge to bind the Tyro3 receptor on stem cells. This binding is the specific event required to trigger the transition from the resting phase ( Telogen) to the growth phase ( Anagen). Crucially, GAS6 is the direct target of Glucocorticoid ( Cortisol) suppression. When stress, sleep deprivation, or rapid weight loss (GLP-1) elevates cortisol, the Dermal Papilla stops producing GAS6, leaving hair follicles stalled in an extended state of quiescence. iPRF acts as a “signal bypass,” activating the growth cycle through parallel pathways even when the GAS6 key is withheld.

GAS6 – Growth arrest-specific protein 6 – is a member of the vitamin K-dependent protein family, structurally related to Protein S, that functions as a ligand for the TAM receptor tyrosine kinases (Tyro3, Axl, and MerTK). It was originally identified in growth-arrested cells, which gave it its name, but its biological roles extend well beyond growth arrest, encompassing cell survival, efferocytosis (clearance of apoptotic cells), immune modulation, and, most relevantly to skin and hair biology, paracrine stem cell activation. ^[1]

In the context of hair follicle biology, GAS6 has a highly specific and well-characterised role that is distinct from most other growth factors involved in the hair cycle. It is not a general proliferative signal or an angiogenic factor, it is the paracrine activation key that dermal papilla cells use to unlock hair follicle stem cell quiescence and initiate a new anagen cycle.

GAS6 and Hair Follicle Stem Cell Activation

Hair follicle stem cells (HFSCs) in the bulge region of the outer root sheath are maintained in quiescence between hair cycles. Transitioning from quiescence to active anagen requires an activation signal from the dermal papilla, and GAS6 is that signal. Dermal papilla cells secrete GAS6 parabolically toward the bulge; HFSCs express the TAM receptor Tyro3 on their surface, through which GAS6 binding initiates the intracellular signalling cascade that activates β-catenin, upregulates Wnt target genes, and commits the HFSC population to anagen entry. ^[1]

The causal specificity of this pathway was established directly: in mice with chronic corticosterone elevation, dermal papilla GAS6 secretion was suppressed, HFSCs remained in extended quiescence, and follicles failed to initiate anagen. When GAS6 was restored by direct delivery into the skin – bypassing the suppressed dermal papilla – hair regrowth resumed. ^[1] This rescue experiment is important because it confirms GAS6 as the specific mediating signal in glucocorticoid-driven follicle quiescence, rather than one of several contributing factors. Without GAS6, the HFSC population has no activation signal regardless of what other growth factors are present.

The GAS6-Tyro3 Activation Relay

What Suppresses GAS6

The most clinically relevant suppressor of GAS6 in the hair follicle context is glucocorticoid elevation – cortisol in humans, corticosterone in rodent models. Chronic glucocorticoid receptor activation in dermal papilla cells downregulates GAS6 gene expression and secretion, withdrawing the HFSC activation signal and extending telogen. ^[1] The sources of chronic glucocorticoid elevation relevant to this mechanism include:

• Persistent psychological stress activating the HPA axis
• Sleep deprivation, which elevates cortisol independently of psychological stressors
• Sustained caloric restriction and rapid weight loss, including GLP-1 medication-driven weight loss
• Age-related upregulation of 11β-HSD1 in skin cells, which locally amplifies cortisol from cortisone independently of systemic stress levels

In all of these contexts, the downstream effect on the hair follicle is the same: GAS6 secretion from DPCs is reduced, HFSCs receive inadequate activation signal, and the follicle cycle stalls in telogen. The telogen effluvium shedding that follows reflects the synchronised exogen phase of follicles that entered telogen simultaneously in response to the shared glucocorticoid signal.

GAS6 suppression is not the only route to follicle quiescence. In androgenetic alopecia, DHT drives a different DPC signalling shift – downregulating Wnt/β-catenin and FGF-7 output whilst upregulating TGF-β2 – that progressively shortens anagen through a separate mechanism. In practice, some clients experiencing significant hair thinning have both AGA and elevated glucocorticoid activity operating simultaneously, compounding the dermal papilla suppression through two independent pathways.

The “GAS6 Veto”: Why Follicles Stall

GAS6 Beyond Hair Follicles

Whilst the hair follicle role is GAS6’s most directly clinically relevant function in this knowledge base, it is worth noting that GAS6’s TAM receptor signalling has broader tissue roles that intersect with skin biology. MerTK-mediated GAS6 signalling in macrophages drives efferocytosis – the clearance of apoptotic cells – and modulates the transition from inflammatory to reparative macrophage phenotypes. ^[1] This connects GAS6 to the macrophage polarisation story described in the Polynucleotides and Dermal entities, where M1-to-M2 macrophage transition is a key part of the tissue repair and regeneration environment. GAS6’s immunomodulatory role is not the primary focus here, but it is a reason the protein appears in broader wound healing and skin repair research beyond the hair follicle context.